Join Drs. Harpole, Higgins, and Stinchcombe as they discuss the latest developments presented during the scientific and educational program at 2021 World Conference on Lung Cancer Worldwide Virtual Event. The webinar will consist of three 15 minute presentations followed by a 15 minute time for question and answers. This webinar is designed to meet the educational needs of physicians, nurses and allied health professionals, pharmacists, patient advocates, and researchers who specialize in diagnostic radiology, hematology, pulmonary medicine, palliative care, medical oncology, thoracic surgery, and radiation oncology.

Dr. Kristin Higgins

Nothing to Disclose
Dr. David Harpole

Scientific Advisory Board: AstraZeneca, Medtronic, Novartis
Steering Committee: AEGEAN
Dr. Thomas Stinchcombe

Advisory Board (ended): Takeda, AstraZeneca, Genentech/Roche, Foundation Medicine, Pfizer, EMD Serono, Novartis, Daiichi Sankyo, Lilly, Medtronic, Puma Biotechnology, Janssen Oncology, Regeneron
Research funding from ineligible companies: Genentech/Roche, Blueprint Medicines, AstraZeneca, Takeda, Advaxis, Regeneron (institution)

At the conclusion of this activity, participants will be able to:
Describe scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies.
Explain advances in the multidisciplinary management of patients in relation to current standards of care.
Identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.